Cargando…

Nasale High Flow Therapie als neue Therapieoption!?

Detalles Bibliográficos
Autor principal: Budweiser, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581548/
https://www.ncbi.nlm.nih.gov/pubmed/36281238
http://dx.doi.org/10.1007/s15033-022-3411-2
_version_ 1784812651626364928
author Budweiser, Stephan
author_facet Budweiser, Stephan
author_sort Budweiser, Stephan
collection PubMed
description
format Online
Article
Text
id pubmed-9581548
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-95815482022-10-20 Nasale High Flow Therapie als neue Therapieoption!? Budweiser, Stephan Pneumo News Journalclub Springer Medizin 2022-10-20 2022 /pmc/articles/PMC9581548/ /pubmed/36281238 http://dx.doi.org/10.1007/s15033-022-3411-2 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Journalclub
Budweiser, Stephan
Nasale High Flow Therapie als neue Therapieoption!?
title Nasale High Flow Therapie als neue Therapieoption!?
title_full Nasale High Flow Therapie als neue Therapieoption!?
title_fullStr Nasale High Flow Therapie als neue Therapieoption!?
title_full_unstemmed Nasale High Flow Therapie als neue Therapieoption!?
title_short Nasale High Flow Therapie als neue Therapieoption!?
title_sort nasale high flow therapie als neue therapieoption!?
topic Journalclub
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581548/
https://www.ncbi.nlm.nih.gov/pubmed/36281238
http://dx.doi.org/10.1007/s15033-022-3411-2
work_keys_str_mv AT budweiserstephan nasalehighflowtherapiealsneuetherapieoption